Based on the documented roles of DANCR and IGF2BP2 in glioma and their correlation in certain cancers, we aimed in this study to explore the interaction between DANCR and IGF2BP2 in drug resistance in GBM cells. This evidence concerns the gene IGF2BP2 and central nervous system cancer.